Overview

The Business Development Manager at Cyted will spearhead the strategic growth and market penetration of our EndoSign device and test within the NHS, specifically in Scotland and NE England. This role involves budgeting, identifying new business opportunities, fostering relationships with key stakeholders, and driving sales initiatives to maximise revenue and market share.

Working Pattern and Location

The role is a full-time position with a standard 37.5 hour working week. The role holder may be required to work flexibly. The Business Development Manager will be home based in North East England or Scotland, with travel to our customers and occasionally to our Head Office in Cambridge.

What You Will Be Doing

• Engage stakeholders across Health Boards, ICBs (Integrated Care Boards), NHS Foundation Trusts, Cancer Alliances, and CDCs (Community Diagnostics Centres) to understand their priorities and challenges and explain how our technology can make a difference to their endoscopy units and waiting lists
• Work with our customers to understand their funding options and develop their business cases
• Close agreements and ensure a smooth transition to onboarding in collaboration with our Customer Success team
• Identify & coordinate opportunities to support our existing customers in collaboration with the Customer Success team in resolving potential implementation & adoption barriers
• Identify & act upon opportunities to expand services in secondary care to access more patients, for example, by working with colleagues in ICBs and CDCs and setting up clinics in community-based settings

How We Work

• Our team works in an agile working environment, where everyone’s ideas and opinions are valued. Have a better way of carrying out a process, we want to hear from you!
• We value user engagement
• We are committed to quality with a strong testing culture
• We work across both our sites to collaborate with all teams

Person Specification

• Background in Diagnostics
• Background in Oncology
• Selling diagnostics (or other similar technology) into secondary or primary care (ideally both)
• Liaising with Heads of Service, Clinical Directors, Heads
• Experience with sales methodologies for example Miller Heiman
• Relatable and personable, and care about building meaningful, genuine relationships with partners across the healthcare system
• Delivery focussed and commercially accountable, understanding that expanding Cyted’s customer base results in better patient outcomes, adding value to the business
• Strong communication, listening and negotiation skills, that enabling them to understand customer needs well and how to structure value propositions in alignment
• Confident in developing actionable business forecasts and holding themselves to account for delivery of key goals and objectives
• Bias for action, willing to get stuck in and make things happen

Benefits

• A competitive salary
• 25 days holiday per holiday year, plus public holidays
• The option to buy 5 additional holidays
• Pension Scheme
• An annual continuing personal development budget
• Medical insurance including dental and optical cover
• Life insurance and Income Protection
• Social events including Christmas and Summer parties
• Cycle to work scheme
• Electric Vehicle Scheme
• Sabbatical after 4 years of service
• Relocation allowance if applicable

About Us

Cyted is on a mission to build a world where disease is prevented rather than treated. We focus on providing innovative diagnostic technologies to drive the earlier detection of disease in the gastrointestinal tract, first focused on oesophageal cancer (and its precursor Barrett’s oesophagus) with a non-endoscopic, minimally-invasive test. Headquartered in Cambridge UK, we lead the way in groundbreaking diagnostic technology, enhancing patient care for those at risk of early and advanced disease. We are on the lookout for talented individuals eager to make a meaningful impact. We strongly encourage applications from underrepresented groups and those with unconventional educational or career backgrounds. Our core product is the minimally invasive EndoSign test. The test is a combination of a simple device coupled with laboratory biomarkers to detect oesophageal cancer and its precursor Barrett’s oesophagus.